Ocular drug delivery; Impact of in vitro cell culture models

Journal of Ophthalmic and Vision Research

Volumn 4, Issue 4, 2014, Pages 238-252

  Barar, Jaleh ^a   Asadi, Masoud ^b   Mortazavi Tabatabaei, Seyed Abdolreza ^a   Omidi, Yadollah ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drug delivery systems; In vitro

Indexed keywords

EID: 84897585235     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Barar J, Javadzadeh AR, Omidi Y. Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv 2008;5:567-581.
2. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 2006;58:1131-1135.
3. Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm 2005;60:207-225.
4. Dartt DA, Hodges RR, Zoukhri D. Tear and Their Secretion. In: Fischbarg J (ed). The biology of the eye. New York: Academic Press; 2006: 21-82.
5. Fullard RJ, Tucker D. Tear protein composition and the effects of stimulus. Adv Exp Med Biol 1994;350:309-314.
6. Macha S, Mitra AK. Overview of ocular drug delivery. In: Mitra AK (ed). Ophthalmic drug delivery systems. 2nd ed. New York: Marcel Dekker; 2003: 1-12.
7. Mitra AK, Anand BS, Duvvuri S. Drug delivery to the eye. In: Fischbarg J (ed). The biology of the eye. New York: Academic Press; 2006: 307-351.
8. Ahmed I. The noncorneal route in ocular drug delivery. In: Mitra AK (ed). Ophthalmic drug delivery systems. 2nd ed. New York: Marcel Dekker; 2003: 335-363.
9. Huang HS, Schoenwald RD, Lach JL. Corneal penetration behavior of beta-blocking agents II: Assessment of barrier contributions. J Pharm Sci 1983;72:1272-1279.
10. Sunkara G, Kompella UB. Membrane transport processes in the eye. In: Mitra AK (ed). Ophthalmic drug delivery systems. New York: Marcel Dekker; 2003: 13-58.
11. Schoenwald RD, Huang HS. Corneal penetration behavior of beta-blocking agents I: physiochemical factors. J Pharm Sci 1983;72:1266-1272.
12. Huang AJ, Tseng SC, Kenyon KR. Paracellular permeability of corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci 1989;30:684-689.
13. Hamalainen KM, Kananen K, Auriola S, Kontturi K, Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci 1997;38:627-634.
14. Janoria KG, Gunda S, Boddu SH, Mitra AK. Novel approaches to retinal drug delivery. Expert Opin Drug Deliv 2007;4:371-388.
15. Duvvuri S, Majumdar S, Mitra AK. Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther 2003;3:45-56.
16. Ahmed I, Patton TF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 1985;26:584-587.
17. Freddo TF. Shifting the paradigm of the bloodaqueous barrier. Exp Eye Res 2001;73:581-592.
18. Cunha-Vaz JG. The blood-ocular barriers: past, present, and future. Doc Ophthalmol 1997;93:149-157.
19. Lin H, Kenyon E, Miller SS. Na-dependent pHi regulatory mechanisms in native human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1992;33:3528-3538.
20. Quinn RH, Miller SS. Ion transport mechanisms in native human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1992;33:3513-3527.
21. Gardner TW, Antonetti DA, Barber AJ, Lieth E, Tarbell JA. The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol 1999;97:229-237.
22. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987;325:253-257.
23. Barar J, Omidi Y. Bioelectrical and permeability properties of brain microvasculature endothelial cells: Effects of tight junction modulators. J Biol Sci 2008;8:556-562.
24. Omidi Y, Barar J, Ahmadian S, Heidari HR, Gumbleton M. Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells. Cell Biochem Funct 2008;26:381-391.
25. Omidi Y, Campbell L, Barar J, Connell D, Akhtar S, Gumbleton M. Evaluation of the immortalised mouse brain capillary endothelial cell line, b. End3, as an in vitro blood-brain barrier model for drug uptake and transport studies. Brain Res 2003; 990:95-112.
26. Smith M, Omidi Y, Gumbleton M. Primary porcine brain microvascular endothelial cells: biochemical and functional characterisation as a model for drug transport and targeting. J Drug Target 2007;15:253-268.
27. Stewart PA, Tuor UI. Blood-eye barriers in the rat: correlation of ultrastructure with function. J Comp Neurol 1994;340:566-576.
28. Selvin BL. Systemic effects of topical ophthalmic medications. South Med J 1983;76:349-358.
29. Antonetti DA, Gardner TW, Barber AJ. Blood-retinal barrier. In: Jaffe GJ, Ashton P, Pearson PA (eds). Intraocular drug delivery. New York: Taylor & Francis; 2006: 27-39.
30. Steuer H, Jaworski A, Stoll D, Schlosshauer B. In vitro model of the outer blood-retina barrier. Brain Res Protoc 2004;13:26-36.
31. Lund-Andersen H, Sebag J, Sander B, La Cour M. The Vitreous. In: Fischbarg J (ed). The biology of the eye. New York: Academic Press; 2006: 181-194.
32. Ghate D, Brooks W, McCarey BE, Edelhauser HF. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci 2007;48: 2230-2237.
33. Ashton P. Retinal drug delivery. In: Jaffe GJ, Ashton P, Pearson PA (eds). Intraocular drug delivery. New York: Taylor & Francis; 2006: 1-25.
34. Guidetti B, Azema J, Malet-Martino M, Martino R. Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers. Curr Drug Deliv 2008;5:7-19.
35. Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res 2004;23:253-281.
36. Omidi Y, Gumbleton M. Biological membranes and barriers. In: Mahato RI (ed). Biomaterials for delivery and targeting of proteins and nucleic acids. New York: CRC Press; 2005: 232-274.
37. Jentsch TJ, Matthes H, Keller SK, Wiederholt M. Anion dependence of electrical effects of bicarbonate and sodium on cultured bovine corneal endothelial cells. Pflugers Arch 1985;403:175-185.
38. Jentsch TJ, Keller SK, Wiederholt M. Ion transport mechanisms in cultured bovine corneal endothelial cells. Curr Eye Res 1985;4:361-369.
39. Gao J, Sun X, Yatsula V, Wymore RS, Mathias RT. Isoform-specific function and distribution of Na/K pumps in the frog lens epithelium. J Membr Biol 2000;178:89-101.
40. Sun XC, Bonanno JA, Jelamskii S, Xie Q. Expression and localization of Na(+)-HCO(3)(-) cotransporter in bovine corneal endothelium. Am J Physiol Cell Physiol 2000;279:C1648-C1655.
41. Mannermaa E, Vellonen KS, Urtti A. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 2006;58:1136-1163.
42. Dey S, Patel J, Anand BS, Jain-Vakkalagadda B, Kaliki P, Pal D, et al. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci 2003;44:2909-2918.
43. Karla PK, Pal D, Quinn T, Mitra AK. Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. Int J Pharm 2007;336:12-21.
44. Holash JA, Stewart PA. The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers. Brain Res 1993;629:218-224.
45. Wu J, Zhang JJ, Koppel H, Jacob TJ. P-glycoprotein regulates a volume-activated chloride current in bovine non-pigmented ciliary epithelial cells. J Physiol 1996;491(Pt 3):743-755.
46. Saha P, Yang JJ, Lee VH. Existence of a pglycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest Ophthalmol Vis Sci 1998;39:1221-1226.
47. Lo WK, Zhou CJ, Reddan J. Identification of caveolae and their signature proteins caveolin 1 and 2 in the lens. Exp Eye Res 2004;79:487-498.
48. Bridges CC, El-Sherbeny A, Roon P, Ola MS, Kekuda R, Ganapathy V, et al. A comparison of caveolae and caveolin-1 to folate receptor alpha in retina and retinal pigment epithelium. Histochem J 2001;33:149-158.
49. Lo WK, Mills A, Zhang W, Zhu H. Polarized distribution of coated pits and coated vesicles in the rat lens: an electron microscopy and WGA-HRP tracer study. Curr Eye Res 1991;10:1151-1163.
50. Hunt RC, Dewey A, Davis AA. Transferrin receptors on the surfaces of retinal pigment epithelial cells are associated with the cytoskeleton. J Cell Sci 1989;92(Pt 4):655-666.
51. Sabah JR, Schultz BD, Brown ZW, Nguyen AT, Reddan J, Takemoto LJ. Transcytotic passage of albumin through lens epithelial cells. Invest Ophthalmol Vis Sci 2007;48:1237-1244.
52. Mo Y, Barnett ME, Takemoto D, Davidson H, Kompella UB. Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene. Mol Vis 2007;13:746-757.
53. Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vis 2003;9:559-568.
54. Parascandola J. The development of the Draize test for eye toxicity. Pharm Hist 1991;33:111-117.
55. Urtti A, Salminen L. Animal pharmacokinetic studies. In: Mitra AK (ed). Ophthalmic drug delivery systems. New York: Marcel Dekker; 1993: 121-136.
56. Barar J, Gumbleton M, Asadi M, Omidi Y. Barrier functionality and transport machineries of human ECV304 cells. Med Sci Monit 2009;16:in press.
57. Toropainen E, Ranta VP, Talvitie A, Suhonen P, Urtti A. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci 2001;42:2942-2948.
58. Hakvoort A, Haselbach M, Wegener J, Hoheisel D, Galla HJ. The polarity of choroid plexus epithelial cells in vitro is improved in serum-free medium. J Neurochem 1998;71:1141-1150.
59. Hoheisel D, Nitz T, Franke H, Wegener J, Hakvoort A, Tilling T, et al. Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem Biophys Res Commun 1998;244:312-316.
60. Ainscough SL, Barnard Z, Upton Z, Harkin DG. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation. Exp Eye Res 2006;83:1505-1514.
61. Ang LP, Cheng ZY, Beuerman RW, Teoh SH, Zhu X, Tan DT. The development of a serum-free derived bioengineered conjunctival epithelial equivalent using an ultrathin poly(epsiloncaprolactone) membrane substrate. Invest Ophthalmol Vis Sci 2006;47:105-112.
62. Chang JE, Basu SK, Lee VH. Air-interface condition promotes the formation of tight corneal epithelial cell layers for drug transport studies. Pharm Res 2000;17:670-676.
63. Yamasaki K, Kawasaki S, Young RD, Fukuoka H, Tanioka H, Nakatsukasa M, et al. Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells. Invest Ophthalmol Vis Sci 2009;50:604-613.
64. Kim HJ, Ryu YH, Ahn JI, Park JK, Kim JC. Characterization of immortalized human corneal endothelial cell line using HPV 16 E6/E7 on lyophilized human amniotic membrane. Korean J Ophthalmol 2006;20:47-54.
65. Kruszewski FH, Walker TL, DiPasquale LC. Evaluation of a human corneal epithelial cell line as an in vitro model for assessing ocular irritation. Fundam Appl Toxicol 1997;36:130-140.
66. Reichl S. Cell culture models of the human cornea-a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro. J Pharm Pharmacol 2008;60:299-307.
67. Becker U, Ehrhardt C, Schneider M, Muys L, Gross D, Eschmann K, et al. A comparative evaluation of corneal epithelial cell cultures for assessing ocular permeability. Altern Lab Anim 2008;36:33-44.
68. Diebold Y, Calonge M, Enriquez de Salamanca A, Callejo S, Corrales RM, Saez V, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci 2003;44:4263-4274.
69. O'Sullivan NL, Baylor AE 3rd, Montgomery PC. Development of immortalized rat conjunctival epithelial cell lines: an in vitro model to examine transepithelial antigen delivery. Exp Eye Res 2007;84:323-331.
70. Saha P, Kim KJ, Lee VH. A primary culture model of rabbit conjunctival epithelial cells exhibiting tight barrier properties. Curr Eye Res 1996;15:1163-1169.
71. Civiale C, Paladino G, Marino C, Trombetta F, Pulvirenti T, Enea V. Multilayer primary epithelial cell culture from bovine conjunctiva as a model for in vitro toxicity tests. Ophthalmic Res 2003;35:126-136.
72. Paladino G, Marino C, La Terra Mule S, Civiale C, Rusciano D, Enea V. Cytokeratin expression in primary epithelial cell culture from bovine conjunctiva. Tissue Cell 2004;36:323-332.
73. Nabi IR, Mathews AP, Cohen-Gould L, Gundersen D, Rodriguez-Boulan E. Immortalization of polarized rat retinal pigment epithelium. J Cell Sci 1993;104(Pt 1):37-49.
74. Cashman SM, Sadowski SL, Morris DJ, Frederick J, Kumar-Singh R. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy. Mol Ther 2002;6:813-823.
75. Mora RC, Bonilha VL, Shin BC, Hu J, Cohen-Gould L, Bok D, et al. Bipolar assembly of caveolae in retinal pigment epithelium. Am J Physiol Cell Physiol 2006;290:C832-C843.
76. Rosenthal R, Bakall B, Kinnick T, Peachey N, Wimmers S, Wadelius C, et al. Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. FASEB J 2006;20:178-180.
77. West KA, Yan L, Miyagi M, Crabb JS, Marmorstein AD, Marmorstein L, et al. Proteome survey of proliferating and differentiating rat RPE-J cells. Exp Eye Res 2001;73:479-491.
78. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci 1995;36:955-964.
79. Mannermaa E, Vellonen KS, Ryhanen T, Kokkonen K, Ranta VP, Kaarniranta K, et al. Efflux protein expression in human retinal pigment epithelium cell lines. Pharm Res 2009;26:1785-1791.
80. Geisen P, McColm JR, King BM, Hartnett ME. Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture. Curr Eye Res 2006;31:739-748.
81. Tuovinen L, Ruhanen E, Kinnarinen T, Ronkko S, Pelkonen J, Urtti A, et al. Starch acetate microparticles for drug delivery into retinal pigment epithelium-in vitro study. J Control Release 2004;98:407-413.
82. Pitkanen L, Ruponen M, Nieminen J, Urtti A. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm Res 2003;20:576-583.
83. Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, D'Amore PA. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res 2003;77:593-599.
84. Chang CW, Ye L, Defoe DM, Caldwell RB. Serum inhibits tight junction formation in cultured pigment epithelial cells. Invest Ophthalmol Vis Sci 1997;38:1082-1093.
85. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996;62:155-169.
86. Gillies MC, Su T, Naidoo D. Electrical resistance and macromolecular permeability of retinal capillary endothelial cells in vitro. Curr Eye Res 1995;14:435-442.
87. Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Ueda M, Yanai N, et al. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp Eye Res 2001;72:163-172.
88. Hosoya K, Tomi M. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol Pharm Bull 2005;28:1-8.
89. Constable PA, Lawrenson JG. Glial cell factors and the outer blood retinal barrier. Ophthalmic Physiol Opt 2009;29:557-564.
90. Shen J, Cross ST, Tang-Liu DD, Welty DF. Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier. Pharm Res 2003;20:1357-1363.
91. Akrami H, Soheili ZS, Khalooghi K, Ahmadieh H, Rezaie-Kanavi M, Samiei S, et al. Retinal Pigment Epithelium culture; a potential source of retinal stem cells. J Ophthalmic Vis Res 2009;4:134-141.